This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Epitarget as, Ic Targets as. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Cecilia Leal Lauten: Innovator in Acoustically Sensitive Drug Delivery
Introduction
Cecilia Leal Lauten is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on acoustically sensitive drug delivery particles. With a total of 3 patents, her inventions are paving the way for more effective treatments in targeted therapies.
Latest Patents
Cecilia's latest patents include groundbreaking technologies that utilize acoustically sensitive drug carrying particles. One of her notable inventions is titled "Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine." This patent discloses novel drug carrying particles that accumulate in diseased target tissues and efficiently release their payload upon exposure to acoustic energy. Another significant patent is "Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine," which similarly focuses on the use of non-lamellar forming lipids for targeted drug delivery.
Career Highlights
Throughout her career, Cecilia has worked with various companies, including Epitarget AS and Ic Targets AS. Her work in these organizations has allowed her to develop and refine her innovative ideas in drug delivery systems.
Collaborations
Cecilia has collaborated with notable professionals in her field, including Sigrid L Fossheim and Esben A Nilssen. These collaborations have further enhanced her research and development efforts.
Conclusion
Cecilia Leal Lauten is a trailblazer in the field of acoustically sensitive drug delivery systems. Her innovative patents and collaborations highlight her commitment to advancing medical technology. Her work continues to inspire future innovations in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile